Predict your next investment

Corporation
HEALTHCARE | Biotechnology
curevac.com

See what CB Insights has to offer

Business Relationships

10

Service Providers

2

CureVac Service Providers

2 Service Providers

CureVac has 2 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

IPO

Investment Bank

Bookrunner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Associated Rounds

IPO

Subscribe to see more

Provider Type

Investment Bank

Subscribe to see more

Service Type

Bookrunner

Subscribe to see more

Partnership data by VentureSource

CureVac Partners & Customers

10 Partners and customers

CureVac has 10 strategic partners and customers. CureVac recently partnered with Bayer on October 10, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

10/15/2021

Partner

Bayer

Germany

Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report

`` Jointly with CureVac we have decided by mutual agreement to not continue the cooperation , '' a Bayer spokesperson told German newspaper Rheinische Post , per Reuters .

2

3/30/2021

Vendor

Celonic

Switzerland

Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV

Celonic is proud to collaborate with CureVac N.V. as part of an expansive manufacturing network in this global fight against COVID-19 by contributing to the production of its mRNA-based COVID-19 vaccine candidate , CVnCoV .

13

2/3/2021

Partner

GlaxoSmithKline

United Kingdom

Glaxo, CureVac Team Up to Develop Next-Generation Covid-19 Shots

-- GlaxoSmithKline Plc and CureVac NV joined forces to create next-generation messenger RNA vaccines to combat emerging variants of the coronavirus that could make the first shots less effective .

8

2/3/2021

Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

11/23/2020

Vendor

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

10/15/2021

3/30/2021

2/3/2021

2/3/2021

11/23/2020

Type

Partner

Vendor

Partner

Partner

Vendor

Business Partner

Bayer

Celonic

GlaxoSmithKline

Country

Germany

Switzerland

United Kingdom

Subscribe to see more

Subscribe to see more

News Snippet

Bayer breaks off Covid-19 vaccine manufacturing pact as CureVac pivots to second-gen work — report

`` Jointly with CureVac we have decided by mutual agreement to not continue the cooperation , '' a Bayer spokesperson told German newspaper Rheinische Post , per Reuters .

Celonic and CureVac Announce Agreement to Manufacture over 100 Million Doses of CureVac’s COVID-19 Vaccine Candidate, CVnCoV

Celonic is proud to collaborate with CureVac N.V. as part of an expansive manufacturing network in this global fight against COVID-19 by contributing to the production of its mRNA-based COVID-19 vaccine candidate , CVnCoV .

Glaxo, CureVac Team Up to Develop Next-Generation Covid-19 Shots

-- GlaxoSmithKline Plc and CureVac NV joined forces to create next-generation messenger RNA vaccines to combat emerging variants of the coronavirus that could make the first shots less effective .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

13

8

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.